Athene Stock Price, News & Analysis (NYSE:ATH)

Athene trades on the New York Stock Exchange (NYSE) under the ticker symbol "ATH."

Athene Holding Ltd (NYSE:ATH) posted its quarterly earnings results on Monday, August, 5th. The insurance provider reported $1.95 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.81 by $0.14. The insurance provider earned $1.16 billion during the quarter, compared to analyst estimates of $1.28 billion. Athene had a net margin of 16.27% and a return on equity of 12.84%. Athene's revenue for the quarter was up 21.2% compared to the same quarter last year. During the same period last year, the firm posted $1.48 EPS. View Athene's Earnings History.

Athene is scheduled to release their next quarterly earnings announcement on Tuesday, November 5th 2019. View Earnings Estimates for Athene.

Athene will be holding an earnings conference call on Tuesday, November 5th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

11 Wall Street analysts have issued 12-month price objectives for Athene's shares. Their forecasts range from $47.00 to $68.00. On average, they anticipate Athene's stock price to reach $54.89 in the next year. This suggests a possible upside of 37.4% from the stock's current price. View Analyst Price Targets for Athene.

11 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Athene in the last year. There are currently 2 hold ratings and 9 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Athene.

News articles about ATH stock have trended very negative recently, InfoTrie Sentiment reports. InfoTrie identifies positive and negative press coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Athene earned a news impact score of -3.3 on InfoTrie's scale. They also assigned news articles about the insurance provider a news buzz of 10.0 out of 10, meaning that recent press coverage is extremely likely to have an impact on the company's share price in the next several days. View News Stories for Athene.

Athene saw a decrease in short interest during the month of September. As of September 30th, there was short interest totalling 3,410,000 shares, a decrease of 12.6% from the August 30th total of 3,900,000 shares. Based on an average daily volume of 1,370,000 shares, the days-to-cover ratio is presently 2.5 days. Approximately 2.4% of the company's shares are sold short. View Athene's Current Options Chain.

Some companies that are related to Athene include Sun Life Financial (SLF), HANNOVER RUECK/S (HVRRY), AVIVA PLC/ADR (AVVIY), Legal & General Group (LGEN), Lincoln National (LNC), AEGON (AEG), Globe Life (GL), Reinsurance Group of America (RGA), SONY FINL HOLDI/ADR (SNYFY), Scor (SCRYY), Voya Financial (VOYA), Primerica (PRI), AMP (AMP), Brighthouse Financial (BHF) and American National Insurance (ANAT).

Based on aggregate information from My MarketBeat watchlists, some companies that other Athene investors own include Alibaba Group (BABA), NVIDIA (NVDA), American Airlines Group (AAL), Amgen (AMGN), Baidu (BIDU), Intel (INTC), Micron Technology (MU), Allergan (AGN), Arista Networks (ANET) and Continental Resources (CLR).

(ATH) raised $952 million in an IPO on Friday, December 9th 2016. The company issued 23,800,000 shares at a price of $38.00-$42.00 per share. Goldman Sachs, Barclays, Citigroup and Wells Fargo Securities acted as the underwriters for the IPO and BofA Merrill Lynch, BMO Capital Markets, Credit Suisse, Deutsche Bank Securities, J.P. Morgan, Morgan Stanley, RBC Capital Markets, BNP PARIBAS, BTIG, Evercore ISI, SunTrust Robinson Humphrey, UBS Investment Bank, Apollo Global Securities, Dowling & Partners Securities, Keefe, Bruyette & Woods (A Stifel Company), Lazard, Raymond James, Rothschild, Sandler O’Neill + Partners and The Williams Capital Group, L.P. were co-managers.

Athene's stock is owned by many different of institutional and retail investors. Top institutional investors include Selz Capital LLC (0.31%), Artemis Investment Management LLP (0.12%), Gofen & Glossberg LLC IL (0.09%), Cerebellum GP LLC (0.01%) and Fox Run Management L.L.C. (0.00%). Company insiders that own Athene stock include Frank Lauren Gillis, Grant Kvalheim, Hope S Taitz, James Richard Belardi, Lawrence Ruisi, Manfred Puffer, Marc A Beilinson and Robert L Borden. View Institutional Ownership Trends for Athene.

ATH stock was sold by a variety of institutional investors in the last quarter, including Selz Capital LLC, Artemis Investment Management LLP and Gofen & Glossberg LLC IL. Company insiders that have sold Athene company stock in the last year include Frank Lauren Gillis, Lawrence Ruisi and Robert L Borden. View Insider Buying and Selling for Athene.

ATH stock was purchased by a variety of institutional investors in the last quarter, including Fox Run Management L.L.C. and Cerebellum GP LLC. Company insiders that have bought Athene stock in the last two years include Grant Kvalheim, James Richard Belardi and Marc A Beilinson. View Insider Buying and Selling for Athene.

Shares of ATH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of ATH stock can currently be purchased for approximately $39.95.

Athene has a market capitalization of $7.49 billion and generates $6.54 billion in revenue each year. The insurance provider earns $1.05 billion in net income (profit) each year or $5.82 on an earnings per share basis. Athene employs 1,275 workers across the globe.View Additional Information About Athene.

The official website for Athene is http://www.athene.com/.

Athene's mailing address is 96 Pitts Bay Road, Pembroke D0, HM08. The insurance provider can be reached via phone at 441-279-8400 or via email at [email protected]